Blood Cancers: Myeloma, Leukemia and Lymphoma
Individualized, Patient-Specific Treatment
Our team focuses on achieving the best outcomes for patients with cancers that affect the blood and bone marrow (myeloma, lymphoma and leukemia) while maximizing long-term health-related quality of life. Our patient-centered care model of care relies on engaging the patient and his or her loved ones in every important aspect of their treatment, including discussions of medical therapies suitable for the patient and the location where care is provided (i.e. hospital or an outpatient facility).
- Patient satisfaction is our goal. Our staff members give patients care and compassion as they receive high-quality clinical care. Read more about philosophy of care in the Journal of Participatory Medicine.
Physicians, nurses, social workers, cancer educators, insurance care managers and other specialists work together with our patients to create a care plan that is customized to the individual’s unique needs—medical, spiritual, social—and addresses their personal goals and values. This is done in full partnership with the patient throughout the journey.
Individualized treatment plans are based on patient-specific factors including: cancer risk (standard or high-risk), fitness (ability to tolerate certain therapies), and individual goals and preferences.
Cumulative scientific data suggests that treatment of hematologic malignancies should be personalized to provide the best outcomes to patients, taking into consideration the uniqueness of each individual. Standard, uniform dosing of medications used to treat blood and bone marrow cancers may result in severe toxic effects, decreased long-term health-related quality of life and survival.
Our team includes dedicated medical hematologist/oncologists, radiation oncologists, pathologists, cancer hospitalists, oncology nurse practitioners and oncology nurses, dieticians, social workers, a psychologist, a nurse educator, a director of quality management and pharmacists with specific experience in treating complex cancers of the blood.
Experts from various medical specialties who are experienced in preventing and/or managing the complications of hematologic cancers and their therapy—including the complications of bone marrow transplantation are also critical members of the team, which is led by an internationally recognized expert in the complications of myeloma and bone marrow.
- Client-Patient Partnerships
Our patient-centered model of care relies on engaging the patient in decisions around all aspects of care. We encourage our patients to become empowered as an active partner in their care. This includes extensive education about your disease, discussion of personalized medical therapies available as well as where they are delivered and understanding patient rights and responsibilities. All of this is done with the goal of reaching a treatment plan that is based on a shared decision between patient and doctor. This full-partnership with the patient also includes the family and other caregivers, with a strong focus on patient and family education from a dedicated nurse educator.